Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
US-10822343-B2 · Nov 3, 2020 · US
This page is not indexed by search engines while we improve data quality.
Remillard Roger patents
Remillard Roger is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Remillard Roger |
| Total patents | 6 |
| First publication | Aug 31, 2017 |
| Latest publication | Nov 3, 2020 |
Notable patents
Publications ranked by popularity score, then publication date.
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (par4) inhibitors for treating platelet aggregation
US-2020123160-A1 · Apr 23, 2020 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
US-10428077-B2 · Oct 1, 2019 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (par4) inhibitors for treating platelet aggregation
US-2018305376-A1 · Oct 25, 2018 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
US-10047103-B2 · Aug 14, 2018 · US
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (par4) inhibitors for treating platelet aggregation
US-2017247395-A1 · Aug 31, 2017 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 6 |
| Univ Montreal | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.